← All companies

CLYM

Climb Bio, Inc.

CLYM Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.81

-0.27 -2.24%

Key statistics

from XBRL data in SEC filings

Market cap

$676M

Revenue (TTM)

—

Net income (TTM)

-$52.8M

EPS (TTM)

$-0.77

P/E ratio

—

Dividend yield

—

Free cash flow

-$54.5M

Cash

$8.36M

Total assets

$152M

Gross margin

—

52-week range

$1.54 – $14.42

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 1, 2026 8-K Entered a material agreement; Other events Jun 12, 2026 8-K Other events Jun 11, 2026 8-K Director or officer change; Shareholder vote results Jun 8, 2026 8-K Other events Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure May 5, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 28, 2026 8-K Director or officer change Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Regulation FD disclosure; Other events Jan 8, 2026 8-K Other events Dec 31, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 17, 2025 8-K Director or officer change Oct 1, 2025 8-K Regulation FD disclosure; Other events Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Director or officer change Jun 18, 2025 8-K Shareholder vote results Jun 5, 2025 8-K Director or officer change May 23, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Director or officer change Apr 1, 2025 8-K Entered a material agreement; Results of operations (earnings release) Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Entered a material agreement; Results of operations (earnings release); Other events Jan 10, 2025 8-K Results of operations (earnings release); Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 15, 2024 8-K Amended charter or bylaws; Other events Oct 2, 2024 8-K Director or officer change Aug 27, 2024 8-K Director or officer change Aug 26, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Jun 27, 2024